Autolus Therapeutics' obe-cel, branded Aucatzyl, is the first CAR-T therapy approved without a REMS, highlighting its safety and unique mechanism.

In this post, we are taking a look at the details of the upcoming Vinfast cars in India in 2025. Vinfast already sells cars ...

TikTok user Caro (@gr86.caro) dedicates much of her social media account to her beloved GR86. But despite the budget-friendly ...

The Syros is Kia's second sub-4m SUV in our market, featuring a distinct boxy design and an upmarket cabin with tech like ...

As American Airlines Flight 5342 descended calmly over the Potomac River, a US army helicopter approached. The outcome was ...

After a nearly $300 million IPO little more than a year ago, a young Peninsula biotech company will discontinue what had been ...

The drug in question, called firicabtagene autoleucel or firi-cel, is an autologous CD22 CAR-T cell therapy that had been ...